Robert G. Adams's most recent trade in National Health Investors, Inc. was a trade of 31,093 Common Stock done at an average price of $79.2 . Disclosure was reported to the exchange on Jan. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors Inc | Robert G. Adams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.23 per share. | 27 Jan 2026 | 31,093 | 184,455 (0%) | 0% | 79.2 | 2,463,498 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 27 Jan 2026 | 25,000 | 205,548 (0%) | 0% | 69.2 | 1,730,000 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2026 | 25,000 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.34 per share. | 27 Jan 2026 | 10,000 | 215,548 (0%) | 0% | 73.3 | 733,400 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2026 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Robert G. Adams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.70 per share. | 28 Mar 2025 | 32,935 | 342,096 (0%) | 0% | 74.7 | 2,460,245 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 25,000 | 0 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. | 28 Mar 2025 | 25,000 | 355,031 (0%) | 0% | 53.4 | 1,335,250 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 28 Mar 2025 | 10,000 | 375,031 (0%) | 0% | 57.8 | 577,600 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Robert G. Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share. | 28 Mar 2025 | 10,000 | 365,031 (0%) | 0% | 54.7 | 547,300 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors Inc | Robert Adams G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors Inc | Robert G. Adams | Director | 01 Oct 2023 | 85,411 | 0 (0%) | 0% | 0 | Common Stock | ||
| National Health Investors Inc | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors Inc | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 56.60 per share. | 14 Dec 2022 | 1,000 | 180,548 (0%) | 0% | 56.6 | 56,600 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Purchase of securities on an exchange or from another person at price $ 65.93 per share. | 15 Aug 2022 | 1,500 | 85,411 (0%) | 0% | 65.9 | 98,895 | Common Stock |
| National Health Investors Inc | Robert G. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to buy) 2022 |